FR2205339A1 - - Google Patents
Info
- Publication number
- FR2205339A1 FR2205339A1 FR7339759A FR7339759A FR2205339A1 FR 2205339 A1 FR2205339 A1 FR 2205339A1 FR 7339759 A FR7339759 A FR 7339759A FR 7339759 A FR7339759 A FR 7339759A FR 2205339 A1 FR2205339 A1 FR 2205339A1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30481572A | 1972-11-08 | 1972-11-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2205339A1 true FR2205339A1 (en) | 1974-05-31 |
FR2205339B1 FR2205339B1 (en) | 1980-01-04 |
Family
ID=23178143
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7339759A Expired FR2205339B1 (en) | 1972-11-08 | 1973-11-08 | |
FR7525565A Granted FR2275452A1 (en) | 1972-11-08 | 1975-08-18 | INTERMEDIARIES WITH TETRAHYDROPYRANYL GROUP USEFUL IN THE SYNTHESIS OF PROSTAGLANDINS |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7525565A Granted FR2275452A1 (en) | 1972-11-08 | 1975-08-18 | INTERMEDIARIES WITH TETRAHYDROPYRANYL GROUP USEFUL IN THE SYNTHESIS OF PROSTAGLANDINS |
Country Status (24)
Country | Link |
---|---|
JP (1) | JPS5644068B2 (en) |
AR (2) | AR204816A1 (en) |
AT (1) | AT347607B (en) |
BE (1) | BE807047A (en) |
CA (1) | CA1027559A (en) |
CH (1) | CH601222A5 (en) |
CS (1) | CS188175B2 (en) |
DD (2) | DD111370A5 (en) |
DE (2) | DE2365999A1 (en) |
ES (2) | ES420326A1 (en) |
FI (1) | FI58116C (en) |
FR (2) | FR2205339B1 (en) |
GB (1) | GB1456511A (en) |
HU (2) | HU171818B (en) |
IE (1) | IE39686B1 (en) |
IL (1) | IL43553A (en) |
IN (1) | IN139905B (en) |
NL (1) | NL7315240A (en) |
NO (2) | NO145437C (en) |
PH (2) | PH15504A (en) |
SE (2) | SE420198B (en) |
SU (2) | SU538659A3 (en) |
YU (2) | YU287973A (en) |
ZA (1) | ZA738593B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2290895A1 (en) * | 1974-11-14 | 1976-06-11 | Upjohn Co | PROSTAGLANDIN ANALOGUE ESTERS, THEIR PREPARATION AND USE |
FR2361381A1 (en) * | 1972-07-13 | 1978-03-10 | Pfizer | (15)-(Hetero) aryl prostaglandin analogues - with long-lasting prostaglandin-like activity |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3929862A (en) * | 1974-01-08 | 1975-12-30 | Upjohn Co | Substituted tolylesters of PGF{HD 2{B {60 |
DE2737807A1 (en) * | 1976-08-27 | 1978-03-09 | Pfizer | C LOW 1 -P-BIPHENYLESTER OF OMEGA-PENTANORPROSTAGLANDINES |
US6531504B2 (en) * | 2001-05-17 | 2003-03-11 | Allergan, Inc. | Prostanoic acid derivatives as agents for lowering intraocular pressure |
-
1973
- 1973-01-01 AR AR250900A patent/AR204816A1/en active
- 1973-11-01 GB GB5088973A patent/GB1456511A/en not_active Expired
- 1973-11-01 SE SE7314885A patent/SE420198B/en unknown
- 1973-11-02 IL IL43553A patent/IL43553A/en unknown
- 1973-11-03 DE DE2365999A patent/DE2365999A1/en not_active Withdrawn
- 1973-11-03 DE DE19732355042 patent/DE2355042A1/en not_active Withdrawn
- 1973-11-06 IN IN2443/CAL/73A patent/IN139905B/en unknown
- 1973-11-07 CA CA185,201A patent/CA1027559A/en not_active Expired
- 1973-11-07 FI FI3444/73A patent/FI58116C/en active
- 1973-11-07 AT AT937173A patent/AT347607B/en not_active IP Right Cessation
- 1973-11-07 NL NL7315240A patent/NL7315240A/xx not_active Application Discontinuation
- 1973-11-07 NO NO4290/73A patent/NO145437C/en unknown
- 1973-11-07 ES ES420326A patent/ES420326A1/en not_active Expired
- 1973-11-07 YU YU02879/73A patent/YU287973A/en unknown
- 1973-11-08 HU HU73PI00000400A patent/HU171818B/en unknown
- 1973-11-08 IE IE2013/73A patent/IE39686B1/en unknown
- 1973-11-08 PH PH15198A patent/PH15504A/en unknown
- 1973-11-08 ZA ZA738593A patent/ZA738593B/en unknown
- 1973-11-08 JP JP12501173A patent/JPS5644068B2/ja not_active Expired
- 1973-11-08 CS CS737670A patent/CS188175B2/en unknown
- 1973-11-08 BE BE1005489A patent/BE807047A/en unknown
- 1973-11-08 HU HU73PI00000453A patent/HU171945B/en unknown
- 1973-11-08 FR FR7339759A patent/FR2205339B1/fr not_active Expired
- 1973-11-08 CH CH1570273A patent/CH601222A5/xx not_active IP Right Cessation
- 1973-11-08 DD DD174537A patent/DD111370A5/xx unknown
- 1973-11-08 DD DD180196*A patent/DD113211A5/xx unknown
- 1973-11-11 SU SU1971421A patent/SU538659A3/en active
-
1974
- 1974-07-31 AR AR254983A patent/AR202311A1/en active
- 1974-10-03 NO NO743588A patent/NO146280C/en unknown
-
1975
- 1975-02-13 ES ES434687A patent/ES434687A1/en not_active Expired
- 1975-03-20 SU SU752115232A patent/SU1021340A3/en active
- 1975-08-18 FR FR7525565A patent/FR2275452A1/en active Granted
-
1976
- 1976-03-12 PH PH18199A patent/PH13794A/en unknown
-
1977
- 1977-04-15 SE SE7704369A patent/SE7704369L/en not_active Application Discontinuation
-
1980
- 1980-10-15 YU YU02644/80A patent/YU264480A/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2361381A1 (en) * | 1972-07-13 | 1978-03-10 | Pfizer | (15)-(Hetero) aryl prostaglandin analogues - with long-lasting prostaglandin-like activity |
FR2290895A1 (en) * | 1974-11-14 | 1976-06-11 | Upjohn Co | PROSTAGLANDIN ANALOGUE ESTERS, THEIR PREPARATION AND USE |
Also Published As
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |